Barr Generic Tambocor Launch Planned For Fall Following Win In Patent Case
Barr is planning to launch a generic version of 3M's Tambocor (flecainide) in the fall following a favorable court decision in a patent infringement case.
Barr is planning to launch a generic version of 3M's Tambocor (flecainide) in the fall following a favorable court decision in a patent infringement case.